About Kristy Delaney
Kristy Delaney, APRN, is a pulmonary nurse practitioner specializing in interstitial lung disease at The University of Kansas Health System. She has over 21 years of experience in medicine, beginning her career as a bedside RN in the Medical ICU before becoming an APRN. For the past 9 years, she has focused her practice on ILD. In addition to her clinical expertise, Kristy holds a degree in Education and is passionate about empowering patients, caregivers, and fellow healthcare professionals through education and support in the management of ILD.
ILD Digital Learning Center by Kristy Delaney
Podcasts
Podcasts
Advances in IPF Clinical Trials
August 2026
29:40 m
In this ILD Community Network Podcast episode, host Kelsey Cramer is joined by Kristy Delaney for a timely discussion on advances in idiopathic pulmonary fibrosis clinical trials and the evolving treatment landscape for IPF and progressive pulmonary fibrosis. Together, they review the TETON clinical development program, including TETON 1, TETON 2, and TETON PPF, and explore the scientific rationale for studying inhaled treprostinil in pulmonary fibrosis following findings from the INCREASE trial. This episode highlights key clinical trial insights related to forced vital capacity, disease progression, time to clinical worsening, background anti-fibrotic therapy, safety, tolerability, cough management, and the potential role of inhaled therapy as an add-on or alternative option for patients with IPF or PPF. Clinicians will gain practical perspective on emerging IPF research, patient selection for new therapies, treatment layering strategies, clinical trial considerations, and how advanced practice providers can stay informed as therapeutic options for interstitial lung disease continue to expand.
Webcast
Webcast
Recognizing and Managing RA-Associated ILD
August 2026
17:35 m
This webcast features a case-based discussion on recognizing and managing rheumatic disease-associated interstitial lung disease (ILD), including rheumatoid arthritis-associated ILD and systemic sclerosis-associated ILD. Through practical clinical scenarios, Kristy Delaney, APRN review key warning signs such as progressive shortness of breath, dry cough, inspiratory crackles, exertional oxygen desaturation, reduced DLCO, and high-risk serologic findings. The session highlights early screening with pulmonary function tests and high-resolution CT, identification of UIP and honeycombing patterns, and treatment considerations involving immunomodulatory and antifibrotic therapies. Multidisciplinary collaboration, patient education, close monitoring, infection prevention, and timely lung transplant evaluation are also emphasized to help slow ILD progression and preserve lung function.
Industry Resources
WANT EXPERT PERSPECTIVES ON INTERSTITIAL LUNG DISEASE?